These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1241 related items for PubMed ID: 17047540
1. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft. Dimar JR, Glassman SD, Burkus KJ, Carreon LY. Spine (Phila Pa 1976); 2006 Oct 15; 31(22):2534-9; discussion 2540. PubMed ID: 17047540 [Abstract] [Full Text] [Related]
4. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis. Crawford CH, Carreon LY, McGinnis MD, Campbell MJ, Glassman SD. Spine (Phila Pa 1976); 2009 Jun 01; 34(13):1390-4. PubMed ID: 19440166 [Abstract] [Full Text] [Related]
5. Re: Dimar JR, Glassman SD, Burkus KJ, et al. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft. Spine 2006; 31:2534-40. Gill JB. Spine (Phila Pa 1976); 2007 Mar 15; 32(6):708; author reply 708. PubMed ID: 17413480 [No Abstract] [Full Text] [Related]
6. Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis. Dimar JR, Glassman SD, Burkus JK, Pryor PW, Hardacker JW, Carreon LY. J Bone Joint Surg Am; 2009 Jun 15; 91(6):1377-86. PubMed ID: 19487515 [Abstract] [Full Text] [Related]
7. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. Haid RW, Branch CL, Alexander JT, Burkus JK. Spine J; 2004 Jun 15; 4(5):527-38; discussion 538-9. PubMed ID: 15363423 [Abstract] [Full Text] [Related]
8. Accelerating autograft maturation in instrumented posterolateral lumbar spinal fusions without donor site morbidity. Rogozinski A, Rogozinski C, Cloud G. Orthopedics; 2009 Nov 15; 32(11):809. PubMed ID: 19902899 [Abstract] [Full Text] [Related]
9. Prospective nonrandomized comparison of an allograft with bone morphogenic protein versus an iliac-crest autograft in anterior cervical discectomy and fusion. Buttermann GR. Spine J; 2008 Nov 15; 8(3):426-35. PubMed ID: 17977799 [Abstract] [Full Text] [Related]
10. Posterolateral lumbar spine fusion with INFUSE bone graft. Glassman SD, Carreon L, Djurasovic M, Campbell MJ, Puno RM, Johnson JR, Dimar JR. Spine J; 2007 Nov 15; 7(1):44-9. PubMed ID: 17197332 [Abstract] [Full Text] [Related]
11. Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes. Slosar PJ, Josey R, Reynolds J. Spine J; 2007 Nov 15; 7(3):301-7. PubMed ID: 17482113 [Abstract] [Full Text] [Related]
12. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion. Akamaru T, Suh D, Boden SD, Kim HS, Minamide A, Louis-Ugbo J. Spine (Phila Pa 1976); 2003 Mar 01; 28(5):429-34. PubMed ID: 12616152 [Abstract] [Full Text] [Related]
13. Long adult spinal deformity fusion to the sacrum using rhBMP-2 versus autogenous iliac crest bone graft. Maeda T, Buchowski JM, Kim YJ, Mishiro T, Bridwell KH. Spine (Phila Pa 1976); 2009 Sep 15; 34(20):2205-12. PubMed ID: 19752707 [Abstract] [Full Text] [Related]
14. Healos and bone marrow aspirate used for lumbar spine fusion: a case controlled study comparing healos with autograft. Neen D, Noyes D, Shaw M, Gwilym S, Fairlie N, Birch N. Spine (Phila Pa 1976); 2006 Aug 15; 31(18):E636-40. PubMed ID: 16915079 [Abstract] [Full Text] [Related]
15. Efficacy of autologous iliac crest bone graft and bone morphogenetic proteins for posterolateral fusion of lumbar spine: a meta-analysis of the results. Papakostidis C, Kontakis G, Bhandari M, Giannoudis PV. Spine (Phila Pa 1976); 2008 Sep 01; 33(19):E680-92. PubMed ID: 18758349 [Abstract] [Full Text] [Related]
16. Blood serum antibody analysis and long-term follow-up of patients treated with recombinant human bone morphogenetic protein-2 in the lumbar spine. Burkus JK, Gornet MF, Glassman SD, Slosar PJ, Rosner MK, Deckey JE, Nowak J, Hatcher BM. Spine (Phila Pa 1976); 2011 Dec 01; 36(25):2158-67. PubMed ID: 21325990 [Abstract] [Full Text] [Related]
17. Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial. Dawson E, Bae HW, Burkus JK, Stambough JL, Glassman SD. J Bone Joint Surg Am; 2009 Jul 01; 91(7):1604-13. PubMed ID: 19571082 [Abstract] [Full Text] [Related]
18. Posterior iliac crest pain after posterolateral fusion with or without iliac crest graft harvest. Howard JM, Glassman SD, Carreon LY. Spine J; 2011 Jun 01; 11(6):534-7. PubMed ID: 20947439 [Abstract] [Full Text] [Related]
19. rhBMP-2 (ACS and CRM formulations) overcomes pseudarthrosis in a New Zealand white rabbit posterolateral fusion model. Lawrence JP, Waked W, Gillon TJ, White AP, Spock CR, Biswas D, Rosenberger P, Troiano N, Albert TJ, Grauer JN. Spine (Phila Pa 1976); 2007 May 15; 32(11):1206-13. PubMed ID: 17495777 [Abstract] [Full Text] [Related]
20. RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a randomized, controlled trial in patients over sixty years of age. Glassman SD, Carreon LY, Djurasovic M, Campbell MJ, Puno RM, Johnson JR, Dimar JR. Spine (Phila Pa 1976); 2008 Dec 15; 33(26):2843-9. PubMed ID: 19092613 [Abstract] [Full Text] [Related] Page: [Next] [New Search]